Ensysce Biosciences Inc.

NASDAQ: ENSC · Real-Time Price · USD
2.10
0.04 (1.94%)
At close: Aug 15, 2025, 3:06 PM

Ensysce Biosciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.78 -3.39 -1 -48.88
PEG Ratio
0.70 0.04 0.02 0.00
PS Ratio
2.73 16.14 9.63 402.60
PB Ratio
3.83 -111.5 -6.03 -174.26
P/FCF Ratio
-0.00 -3.34 -1.36 -172.48
P/OCF Ratio
-0.00 -3.34 -1.36 -172.48
OCF/S Ratio
-1.44M -4.83 -7.09 -2.33
Debt / Equity Ratio
0.08 -2.65 -1.1 -2.11
Quick Ratio
2.42 0.69 0.59 0.98
Current Ratio
2.42 0.69 0.56 0.95
Asset Turnover
0.93 0.82 0.43 0.22
Interest Coverage
-5.22 -30.28 -221.15 -15.34
Return on Equity
-2.15 32.87 6.00 3.57
Return on Assets
-1.43 -3.92 -4.11 -1.77
Return on Invested Capital
-1.82 -46.64 -33.89 -1.56
Dividend Yield
20.39 n/a 0.04 564.96
Payout Ratio
-36.31 n/a -0.04 -27.61K
Gross Profit Margin
-0.39 -2.4 -6.86 1.00
Net Profit Margin
-1.53 -4.76 -9.58 -8.24
Pretax Profit Margin
-1.53 -4.76 -9.59 -8.25
Operating Profit Margin
-1.29 -4.8 -9.6 -5.63
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.29 -4.8 -9.6 -5.63